[Latin Name] Haematococcus Pluvialis

[Plant Source] from China

[Specifications]1% 2% 3% 5%

[Appearance] Dark red Powder

[Particle size] 80 Mesh

[Loss on drying] ≤5.0%

[Heavy Metal] ≤10PPM

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life] 24 Months

[Package] Packed in paper-drums and two plastic-bags inside.

[Net weight] 25kgs/drum

Brief Introduction

Astaxanthin is a natural nutritional component, it can be found as a food supplement. The supplement is intended for human, animal, and aquaculture consumption.

Astaxanthin is a carotenoid. It belongs to a larger class of phytochemicals known as terpenes, which are built from five carbon precursors; isopentenyl diphosphate and dimethylallyl diphosphate . Astaxanthin is classified as a xanthophyll (originally derived from a word meaning “yellow leaves” since yellow plant leaf pigments were the first recognized of the xanthophyll family of carotenoids), but currently employed to describe carotenoid compounds that have oxygen-containing moities, hydroxyl or ketone , such as zeaxanthin and canthaxanthin. Indeed, astaxanthin is a metabolite of zeaxanthin and/or canthaxanthin, containing both hydroxyl and ketone functional groups. Like many carotenoids, astaxanthin is a colorful, lipid-soluble pigment. This colour is due to the extended chain of conjugated (alternating double and single) double bonds at the centre of the compound. This chain of conjugated double bonds is also responsible for the antioxidant function of astaxanthin (as well as other carotenoids) as it results in a region of decentralized electrons that can be donated to reduce a reactive oxidizing molecule.

Function:

1.Astaxanthin is a powerful antioxidant and may protect against oxidative damage to body tissues.

2.Astaxanthin can improve the immune response by increasing the number of antibody producing cells.

3.Astaxanthin is a potential candidate to treat neurodegenerative disease such as Alzhimer and Parkinson diease.

4.Astaxanthin dan reduce UVA-light damage to skin such as sunburn, inflammation, ageing and skin cancer.

Application

1.When applied in pharmaceutical field, astaxanthin powder has the good function of antineoplastic;

2.When applied in health food field, astaxanthin powder is used as food additives for pigment and health care;

3.When applied in cosmetic field, astaxanthin powder has the good function of antioxidant and anti-aging;

4.When applied in animal feeds field, astaxanthin powder is used as animal feed additive to impart coloration, including farm-raised salmon and egg yolks.

Amazing Health Benefits Of Oranges:

Oranges have many health benefits. They are rich in Vitamins C and A, flavonoids, antioxidants, potassium, calcium, magnesium, dietary fiber etc. Oranges have more than 60 flavonoids and 170 phytonutrients that have been shown to have anti-inflammatory, anti-cancer/tumour and anti-oxidant properties.

Subscribe to our channel for more health tips: https://www.youtube.com/channel/UCQ4XDPcNa-CdeBA6F8Dncew

Visit this link to read more health benefits of oranges (https://www.yourhealthylifeonline.com/tangerines-health-benifits-tangerines).

Thanks for watching this health benefits of oranges video. Please like, comment, subscribe and share this video.

Amazing Health Benefits Of Oranges (https://youtu.be/0MWDU0t-wZA)

QUFU, China, Jan. 7, 2013 /PRNewswire/ — Sunwin Stevia International, Inc. “Sunwin Stevia” (SUWN) one of the top global providers of high quality stevia extracts including Rebaudioside A 98, announced today that its facilities are now capable of producing A3-99 stevia products. The addition of A3-99 to its commercial production capabilities is part of its previously announced stevioside expansion project.
A3-99 extracts are among the highest quality stevioside extracts produced in the world and are used in the pharmaceutical and food and beverage industries. Sunwin Stevia has completed testing for this production process making it one of a select few producers of A3-99 in China. Management expects to begin delivering shipments of the A3-99 to Zhejiang Huisong Pharmaceuticals, a pharmaceutical customer in China, in the fourth quarter of fiscal 2013 which begins in February 2013. Sunwin also intends to seek patents in China for its A3-99 production methodology.
“We are excited to add A3-99 to our commercial product offerings making Sunwin Stevia one of a select few suppliers capable of producing this extract on a large scale. Our recent facility upgrade has substantially increased our overall capabilities and we anticipate further additions to our production capabilities as we continue testing and trial production runs,” commented Dongdong Lin, CEO of Sunwin Stevia. “We believe our technology is state of the art and we intend to seek a patent for our methodologies. We look forward to actively marketing our A3-99 stevia in China and eventually in the international markets in the coming quarters.”
About Sunwin Stevia International, Inc.
Sunwin Stevia International, Inc. engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit https://www.sunwininternational.com
Safe Harbor Statement
Sunwin Stevia International, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our ability to obtain patents, future production capabilities, our technology and the market for our products, and other risk factors impacting our company, some of which may be beyond our control. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2012.
Contact:

Dore Perler
U.S. Representative
954-232-5363
ir@sunwininternational.com